The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dessein, A. J.
Right arrow Articles by Bina, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dessein, A. J.
Right arrow Articles by Bina, J. C.

The Journal of Immunology, Vol 140, Issue 8 2727-2736, Copyright © 1988 by American Association of Immunologists

ARTICLES

Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen

AJ Dessein, M Begley, C Demeure, D Caillol, J Fueri, MG dos Reis, ZA Andrade, A Prata and JC Bina
Centre d'Immunologie de Marseille-Luminy, France.

The aim of this work was to determine whether human resistance to Schistosoma mansoni was associated with increased antibody reactivity to certain larval surface Ag. To this end, young residents of a hyperendemic area were selected for their low or high susceptibility to reinfection after parasitologic cure, and the reactivity of their sera to individual larval surface Ag was determined at different times before and after treatment. The data showed that six Ag: 202, 165, 90 to 92, 85, 72, and 37 kDa are the principal targets on the larva of IgG in the sera of resistant subjects. The comparative study, by immunoblotting and ELISA on purified Ag, of the sera from high and low susceptibility subjects indicates that IgG reactivity toward the 37-kDa Ag may be associated with resistance. This work and ongoing vaccination trials carried out in mice suggest that the 37-kDa Ag may have vaccinating potentials.


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
T. Leenstra, L. P. Acosta, H.-W. Wu, G. C. Langdon, J. S. Solomon, D. L. Manalo, L. Su, M. Jiz, B. Jarilla, A. O. Pablo, et al.
T-Helper-2 Cytokine Responses to Sj97 Predict Resistance to Reinfection with Schistosoma japonicum
Infect. Immun., January 1, 2006; 74(1): 370 - 381.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Kouriba, C. Chevillard, J. H. Bream, L. Argiro, H. Dessein, V. Arnaud, L. Sangare, A. Dabo, A. H. Beavogui, C. Arama, et al.
Analysis of the 5q31-q33 Locus Shows an Association between IL13-1055C/T IL-13-591A/G Polymorphisms and Schistosoma haematobium Infections
J. Immunol., May 15, 2005; 174(10): 6274 - 6281.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
G. M. S. ROSINHA, A. MYIOSHI, V. AZEVEDO, G. A. SPLITTER, and S. C. OLIVEIRA
Molecular and immunological characterisation of recombinant Brucella abortus glyceraldehyde-3-phosphate-dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administered with an interleukin-12-expressing plasmid in a DNA vaccine formulation
J. Med. Microbiol., August 1, 2002; 51(8): 661 - 671.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
A. G. P. Ross, A. C. Sleigh, Y. Li, G. M. Davis, G. M. Williams, Z. Jiang, Z. Feng, and D. P. McManus
Schistosomiasis in the People's Republic of China: Prospects and Challenges for the 21st Century
Clin. Microbiol. Rev., April 1, 2001; 14(2): 270 - 295.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
Alain. J. Dessein, C. Chevillard, S. Marquet, S. Henri, D. Hillaire, and H. Dessein
Genetics of Parasitic Infections
Drug Metab. Dispos., April 1, 2001; 29(4): 484 - 488.
[Abstract] [Full Text]

Home page
 Infect. Immun.Home page
R. El Ridi, C. B. Shoemaker, F. Farouk, N. H. El Sherif, and A. Afifi
Human T- and B-Cell Responses to Schistosoma mansoni Recombinant Glyceraldehyde 3-Phosphate Dehydrogenase Correlate with Resistance to Reinfection with S. mansoni or Schistosoma haematobium after Chemotherapy
Infect. Immun., January 1, 2001; 69(1): 237 - 244.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Ribeiro de Jesus, I. Araujo, O. Bacellar, A. Magalhaes, E. Pearce, D. Harn, M. Strand, and E. M. Carvalho
Human Immune Responses to Schistosoma mansoni Vaccine Candidate Antigens
Infect. Immun., May 1, 2000; 68(5): 2797 - 2803.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
V. Rodrigues Jr., K. Piper, P. Couissinier-Paris, O. Bacelar, H. Dessein, and A. J. Dessein
Genetic Control of Schistosome Infections by the SM1 Locus of the 5q31-q33 Region Is Linked to Differentiation of Type 2 Helper T Lymphocytes
Infect. Immun., September 1, 1999; 67(9): 4689 - 4692.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
O. Roye, N. Delhem, F. Trottein, F. Remoue, S. Nutten, J.-P. Decavel, M. Delacre, V. Martinot, J.-Y. Cesbron, C. Auriault, et al.
Dermal Endothelial Cells and Keratinocytes Produce IL-7 In Vivo After Human Schistosoma mansoni Percutaneous Infection
J. Immunol., October 15, 1998; 161(8): 4161 - 4168.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.